The Danish government has appointed the BioInnovation Institute (BII) in Copenhagen as the site for a new project to support entrepreneurs involved in quantum science research. The initiative adds a new dimension to the institute, which was created in 2017 to advance research and enterprise in the life science industry. The institute was started by the Novo Nordisk Foundation, an independent charity which owns Novo Holdings A/S, the majority shareholder of Novo Nordisk A/S. The foundation provided grant funding for the BII until 2021 when it became financially independent.
